Swiss pharmaceutical giant Novartis completed the spin-off of its eye care business and shares of Alcon started trading today, closing up 0.2% above the opening price to $58.04. Shares of Novartis. However, in April 2019, Alcon's spin-off from Novartis was completed, making it a wholly independent company. With Sandoz, Novartis has also a strong generic drug division.... Novartis AG's. May 26, 2022 · AbbVie has been a volatile pharma stock over the last few years, racing from the low $50s near the end of 2016 to a high of about $120 in 2018, before plunging back to $65 or so amid the pandemic.